NYSE · HLN
Haleon financials
$9.07−1.09%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| Net margin | — | — | — | — |
| Diluted EPS | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — |
| Free cash flow | — | — | — | — |
| Diluted shares | 9,026.0M | 9,175.0M | 9,263.0M | 9,239.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $1.78B | $2.82B | $1.33B | $684.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $11.58B | $12.93B | $12.04B | $10.44B |
| Total assets | $43.88B | $43.06B | $43.35B | $34.81B |
| Total liabilities | $21.71B | $22.70B | $22.06B | $18.36B |
| Shareholders' equity | $22.17B | $20.36B | $21.30B | $16.46B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology